Lynch Thomas G 4
4 · Evofem Biosciences, Inc. · Filed Apr 1, 2020
Insider Transaction Report
Form 4
Lynch Thomas G
Director
Transactions
- Exercise/Conversion
Common Stock
2020-03-31+37,500→ 325,000 total - Exercise/Conversion
Restricted Stock Units
2020-03-31+37,500→ 0 total→ Common Stock (37,500 underlying) - Award
Restricted Stock Units
2020-04-01+150,000→ 150,000 total→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services to be provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer effective April 1, 2019.
- [F2]The restricted stock units shall vest in four equal installments on June 30, 2019, September 30, 2019, December 31, 2019 and March 31, 2020.
- [F3]The restricted stock units shall vest in four equal installments on June 30, 2020, September 30, 2020, December 31, 2020 and March 31, 2021.